“Long-term Safety and Efficacy of Difelikefalin in Subjects With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2”, J of Skin, vol. 5, no. 6, p. s75, Nov. 2021, doi: 10.25251/skin.5.supp.75.